Literature DB >> 15996102

DNA cytosine C5 methyltransferase Dnmt1: catalysis-dependent release of allosteric inhibition.

Zeljko M Svedruzić1, Norbert O Reich.   

Abstract

We followed the cytosine C(5) exchange reaction with Dnmt1 to characterize its preference for different DNA substrates, its allosteric regulation, and to provide a basis for comparison with the bacterial enzymes. We determined that the methyl transfer is rate-limiting, and steps up to and including the cysteine-cytosine covalent intermediate are in rapid equilibrium. Changes in these rapid equilibrium steps account for many of the previously described features of Dnmt1 catalysis and specificity including faster reactions with premethylated DNA versus unmethylated DNA, faster reactions with DNA in which guanine is replaced with inosine [poly(dC-dG) vs poly(dI-dC)], and 10-100-fold slower catalytic rates with Dnmt1 relative to the bacterial enzyme M.HhaI. Dnmt1 interactions with the guanine within the CpG recognition site can prevent the premature release of the target base and solvent access to the active site that could lead to mutagenic deamination. Our results suggest that the beta-elimination step following methyl transfer is not mediated by free solvent. Dnmt1 shows a kinetic lag in product formation and allosteric inhibition with unmethylated DNA that is not observed with premethylated DNA. Thus, we suggest the enzyme undergoes a slow relief from allosteric inhibition upon initiation of catalysis on unmethylated DNA. Notably, this relief from allosteric inhibition is not caused by self-activation through the initial methylation reaction, as the same effect is observed during the cytosine C(5) exchange reaction in the absence of AdoMet. We describe limitations in the Michaelis-Menten kinetic analysis of Dnmt1 and suggest alternative approaches.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996102     DOI: 10.1021/bi050295z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  DNA methyl transferase 1: regulatory mechanisms and implications in health and disease.

Authors:  Sirano Dhe-Paganon; Farisa Syeda; Lawrence Park
Journal:  Int J Biochem Mol Biol       Date:  2011-01-30

Review 2.  Crosstalk between metabolism and epigenetic modifications in autoimmune diseases: a comprehensive overview.

Authors:  Zijun Wang; Hai Long; Christopher Chang; Ming Zhao; Qianjin Lu
Journal:  Cell Mol Life Sci       Date:  2018-07-04       Impact factor: 9.261

3.  Crystal Structure of Human DNA Methyltransferase 1.

Authors:  Zhi-Min Zhang; Shuo Liu; Krystal Lin; Youfu Luo; John Jefferson Perry; Yinsheng Wang; Jikui Song
Journal:  J Mol Biol       Date:  2015-06-10       Impact factor: 5.469

Review 4.  An insight into the various regulatory mechanisms modulating human DNA methyltransferase 1 stability and function.

Authors:  Swayamsiddha Kar; Moonmoon Deb; Dipta Sengupta; Arunima Shilpi; Sabnam Parbin; Jérôme Torrisani; Sriharsa Pradhan; Samir Patra
Journal:  Epigenetics       Date:  2012-08-16       Impact factor: 4.528

Review 5.  Molecular and enzymatic profiles of mammalian DNA methyltransferases: structures and targets for drugs.

Authors:  F Xu; C Mao; Y Ding; C Rui; L Wu; A Shi; H Zhang; L Zhang; Z Xu
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

6.  The replication focus targeting sequence (RFTS) domain is a DNA-competitive inhibitor of Dnmt1.

Authors:  Farisa Syeda; Rebecca L Fagan; Matthew Wean; George V Avvakumov; John R Walker; Sheng Xue; Sirano Dhe-Paganon; Charles Brenner
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

7.  Characterizing DNA methyltransferases with an ultrasensitive luciferase-linked continuous assay.

Authors:  Ivan Hemeon; Jemy A Gutierrez; Meng-Chiao Ho; Vern L Schramm
Journal:  Anal Chem       Date:  2011-05-16       Impact factor: 6.986

8.  A real-time assay for CpG-specific cytosine-C5 methyltransferase activity.

Authors:  Robert J Wood; Jennifer C McKelvie; Michael D Maynard-Smith; Peter L Roach
Journal:  Nucleic Acids Res       Date:  2010-02-05       Impact factor: 16.971

9.  DNA (Cytosine-C5) methyltransferase inhibition by oligodeoxyribonucleotides containing 2-(1H)-pyrimidinone (zebularine aglycon) at the enzymatic target site.

Authors:  Dana M van Bemmel; Adam S Brank; Ramon Eritja; Victor E Marquez; Judith K Christman
Journal:  Biochem Pharmacol       Date:  2009-05-23       Impact factor: 5.858

10.  A versatile non-radioactive assay for DNA methyltransferase activity and DNA binding.

Authors:  Carina Frauer; Heinrich Leonhardt
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.